115 results
Page 5 of 6
6-K
EX-99.2
1mytmv
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
EX-99.2
5b79fx8
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
z1fhm0i6mfgf xconrt3
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.3
fgk54x1 exxq
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.2
imbxbvkbn1kt h53vam
7 Nov 19
Current report (foreign)
9:11am
6-K
EX-99.1
a6p3g
31 Oct 19
ObsEva Announces Clearance to Initiate Pivotal US Phase 3 Clinical
4:21pm
6-K
EX-99.1
tev5uj
6 Sep 19
ObsEva Reports New Clinical Evidence of Nolasiban Mechanism of
8:27am
424B5
jaamoi gm
7 Aug 19
Prospectus supplement for primary offering
8:18am
6-K
EX-99.1
o9e h1i08vd
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.2
s7n 4vcplb
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.3
n6ygrefkqlsme
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
u4buk
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.2
0enj91psvfpdw0l
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
zngt7u3ylutffuf4
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
6x4 mr80h5dk1ue
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
EX-99.2
jrqibak
8 Nov 18
Index to Unaudited Condensed Consolidated Financial Statements
9:28am
6-K
5obg j3mr7q
9 Oct 18
Current report (foreign)
4:42pm
6-K
pznuau13q0 ow11
3 Oct 18
Current report (foreign)
9:07am
6-K
7szcs4 ix
28 Sep 18
Current report (foreign)
8:40am